Biochemical and immunological study in Iraqi patients with brain tumor

From November 2021 to February 2022, researchers at Al-Hussein Hospital in Karbala, Iraq, will investigate the prevalence of bacteremia and immunological markers in patients with brain tumors. 50 patients with brain tumors (27 males, 23 females) and 30 healthy people as controls. Both patients and controls had blood drawn. Blood urea, creatinine, alkaline phosphate, and CKBB were measured by Fujifilm, and interleukin-12 (IL-12) by ELISA. The findings indicated that the most vulnerable age group was 1-10 year olds, with a 26% infection rate compared to other age groups. The average urea level in patients was 29.74 mg/dl compared to 28.21 mg/dl in healthy controls, indicating no significant difference between the two groups, unlike creatinine, which was higher in patients 0.6 mg/dl compared to 0.4 mg/dl in their parents, with a p 0.01 significant difference. Also, the level of Alkaline Phosphatase (188.22 U/L) was not substantially different from the healthy (187.76 U/L), nor was the level of CK-BB (p>0.005). Interleukin-12 levels in patients are lower than in healthy control